8 assets in Endocervical Adenocarcinoma

Therapeutic assets addressing Endocervical Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
e7 tcr-t cells Endocervical Adenocarcinoma	Christian Hinrichs	P2	B (58)
Tsc-200-A0201 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-201-B0702 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-202-A0201 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-203-A0201 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-C0702 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)